Classification of anti-Parkinsonian drugs
Several drug classes are used to correct motor disorders in parkinsonism, each having its own site of action in the nervous system.
Modern classification distinguishes the following main groups:
- Dopamine receptor agonists. A representative of this group is bromocriptine.
- Central anticholinergics. These include trihexyphenidyl.
- Glutamate NMDA receptor blockers. The main drug is amantadine.
- Levodopa preparations. Levodopa itself acts as the baseline therapeutic agent.
- Peripheral decarboxylase inhibitors. Include drugs such as carbidopa and benserazide. They are used exclusively as an auxiliary component to protect the main active substance.
Mechanism of action of levodopa
The pharmacological effect of levodopa is based on its ability to stimulate dopaminergic transmission in brain structures.
Levodopa itself is a biochemical precursor of dopamine. To exert a therapeutic effect, the drug molecule must physically penetrate from the bloodstream into the brain tissue. The main obstacle on this path is the blood-brain barrier (BBB), which isolates the central nervous system. Upon entering the CNS, the precursor is transformed into the active neurotransmitter, compensating for its deficiency.
Principles of combination therapy
The use of pure levodopa is associated with a serious pharmacokinetic problem. The body contains an enzyme — aromatic L-amino acid decarboxylase. If a patient takes the drug without protection, this enzyme begins to actively metabolize levodopa into dopamine in peripheral tissues (before the drug reaches the brain).
The dopamine formed in the periphery is unable to cross the blood-brain barrier.
To solve this problem, combination therapy is used by combining levodopa with carbidopa (or benserazide).
Goal and result of the combination:
- Carbidopa provides reliable blockade of the decarboxylase enzyme strictly in peripheral tissues.
- Premature metabolism of levodopa into dopamine in the periphery is prevented.
- As a result, a significantly larger amount of unchanged drug successfully penetrates through the BBB directly into the central nervous system.
Briefly: answers to topical questions
What is the full mechanism of the antiparkinsonian action of amantadine?
Amantadine has a mixed mechanism of action, affecting both the dopamine and glutamate neurotransmitter systems.
- Dopaminergic mechanism — enhances dopamine release from intact presynaptic terminals and impairs its neuronal reuptake.
- Antiglutamatergic mechanism — blocks NMDA receptors on cholinergic neurons of the basal ganglia, preventing the stimulating effect of glutamate and inhibiting cholinergic transmission in the neostriatum.
- Anticholinergic mechanism — possesses some intrinsic anticholinergic activity.
What adverse effects are typical for long-term therapy with levodopa preparations?
Therapy with levodopa preparations may lead to adverse effects involving various organ systems.
- Psychoneurological disorders — psychosis, hallucinations, anxiety, depression, insomnia, somnolence, and coordination disturbances.
- Cardiovascular disorders — tachycardia and various types of cardiac arrhythmias associated with the peripheral conversion of levodopa to dopamine and stimulation of myocardial $\beta$-adrenoreceptors.
- Gastrointestinal disorders — dyspeptic symptoms, in particular vomiting due to stimulation of the trigger zone of the vomiting center.
Which drugs, besides bromocriptine, belong to the group of dopamine receptor agonists?
The group of dopamine receptor agonists, in addition to bromocriptine, includes the following drugs:
- Pergolide — a non-selective agonist derived from ergot alkaloids.
- Pramipexole — a non-selective agonist stimulating D2 and D3-type receptors.
- Ropinirole — a drug used, among other things, in extended-release formulations.
- Piribedil — a drug that additionally enhances noradrenergic transmission.
What is the fundamental difference in the mechanism of action between levodopa and bromocriptine?
The fundamental difference is that levodopa is a neurotransmitter precursor, whereas bromocriptine is a direct receptor agonist.
| Characteristic | Levodopa (Levodopa) | Bromocriptine (Bromocriptine) |
|---|---|---|
| Mechanism of action | Dopamine precursor requiring metabolic conversion | Direct dopamine receptor agonist |
| Site of action | Converted to dopamine by DOPA decarboxylase | Direct excitation of receptors in the neostriatum |
What is the role of COMT inhibitors (entacapone) in the combination therapy of parkinsonism?
COMT inhibitors block the catabolic pathways of levodopa and dopamine. Entacapone is used in combination with levodopa and carbidopa. This combination is used to manage motor fluctuations.
To remember the essence of the combination, imagine: Levodopa is an "important cargo" heading to the brain, and Carbidopa is a "bodyguard" that distracts peripheral enzymes, allowing the cargo to safely cross the blood-brain barrier.
Class and exam questions
What is the primary mechanism of action of levodopa?
Levodopa is a dopamine precursor. Its main effect is due to the stimulation of dopaminergic transmission in the central nervous system.
What role does carbidopa play in treatment?
Carbidopa acts as an auxiliary component. It blocks the aromatic L-amino acid decarboxylase enzyme in the periphery, preventing levodopa from breaking down before reaching the brain.
What barrier must levodopa cross to exert its effect?
The drug must penetrate the blood-brain barrier (BBB) to enter the central nervous system.
What else to study on this topic
- Mechanism of action of central anticholinergics (trihexyphenidyl)
- Pharmacodynamics of dopamine receptor agonists (bromocriptine)
- Blockade of glutamate NMDA receptors: effects of amantadine
- Comparative characteristics of peripheral decarboxylase inhibitors (carbidopa and benserazide)
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Principles of Pharmacotherapy of Parkinsonism" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.